isoproterenol has been researched along with deferoxamine in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (21.05) | 18.7374 |
| 1990's | 6 (31.58) | 18.2507 |
| 2000's | 3 (15.79) | 29.6817 |
| 2010's | 4 (21.05) | 24.3611 |
| 2020's | 2 (10.53) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
| Abdel-Latif, AA; Akhtar, RA; Tachado, SD; Zhou, CJ | 1 |
| Svoboda, P; Teisinger, J; Vyskocil, F | 1 |
| Bardin, CW; Gunsalus, GL; Mather, JP; Musto, NA; Perez-Infante, V; Rich, KA | 1 |
| Filpi, RG; LoPresti, JM; Majd, M | 1 |
| Artman, M; Boerth, RC; Boucek, RJ; Ghishan, FK; Olson, RD | 1 |
| Babin-Chevaye, C; Franzini, E; Hakim, J; Marquetty, C; Pasquier, C; Sellak, H | 1 |
| Aguirre, DE; Johnson, RG; Sellke, FW; Stamler, A; Wang, SY | 1 |
| Aksentsev, SL; Hamet, P; Orlov, SN; Pokudin, NI; Tremblay, J | 1 |
| Neumann, J; Scholz, H | 1 |
| DePinho, RA; Eisen, AM; Gallo, V; Ghiani, CA; Knutson, PL; McBain, CJ; Yuan, X | 1 |
| Johnston, WK; Mahoney, JR; Minnear, FL; Morton, CA; Vincent, PA; Waypa, GB | 1 |
| He, P; Wang, J; Zeng, M | 1 |
| Bobrovová, Z; Haskova, P; Holeckova, M; Hrdina, R; Jansson, PJ; Kalinowski, DS; Mazurová, Y; Mladĕnka, P; Nachtigal, P; Palicka, V; Richardson, DR; Semecký, V; Simůnek, T; Vávrová, J | 1 |
| Hashimoto, T; Higashida, K; Inoue, S; Nakai, N; Takeuchi, N | 1 |
| Johnson, AC; Zager, RA | 1 |
1 review(s) available for isoproterenol and deferoxamine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
18 other study(ies) available for isoproterenol and deferoxamine
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Effects of isoproterenol and forskolin on carbachol- and fluoroaluminate-induced polyphosphoinositide hydrolysis, inositol trisphosphate production, and contraction in bovine iris sphincter smooth muscle: interaction between cAMP and IP3 second messenger
Topics: Aluminum; Animals; Carbachol; Cattle; Colforsin; Cyclic AMP; Deferoxamine; Fluorine; Hydrolysis; Inositol 1,4,5-Trisphosphate; Iris; Isoproterenol; Kinetics; Muscle Contraction; Muscle, Smooth; Phosphatidylinositol 4,5-Diphosphate; Phosphatidylinositols; Phosphorylation; Second Messenger Systems; Sodium Fluoride | 1992 |
Effect of catecholamines and metal chelating agents on the brain and brown adipose tissue Na,K-ATPase.
Topics: Adipose Tissue, Brown; Animals; Catecholamines; Cerebral Cortex; Chelating Agents; Deferoxamine; Edetic Acid; Egtazic Acid; Epinephrine; Isoproterenol; Kinetics; Microsomes; Norepinephrine; Rats; Rats, Inbred Strains; Sodium-Potassium-Exchanging ATPase; Stereoisomerism; Subcellular Fractions | 1986 |
Differential regulation of testicular transferrin and androgen-binding protein secretion in primary cultures of rat Sertoli cells.
Topics: Aging; Androgen-Binding Protein; Animals; Blood; Cell Count; Cells, Cultured; Deferoxamine; Epidermal Growth Factor; Follicle Stimulating Hormone; Insulin; Iron; Isoproterenol; Male; Rats; Sertoli Cells; Testosterone; Transferrin; Tretinoin | 1986 |
Reversible gastric stricture following iron ingestion.
Topics: Blood Transfusion; Cathartics; Constriction; Deferoxamine; Gastric Lavage; Gastrointestinal Hemorrhage; Humans; Infant; Iron; Isoproterenol; Poisoning; Radiography; Stomach Diseases; Sulfates; Time Factors | 1973 |
Acute effects of iron on contractile function in isolated rabbit myocardium.
Topics: Animals; Deferoxamine; Drug Interactions; Female; Heart Rate; In Vitro Techniques; Iron; Isoproterenol; Male; Myocardial Contraction; Rabbits | 1984 |
Inhibition of human neutrophil binding to hydrogen peroxide-treated endothelial cells by cAMP and hydroxyl radical scavengers.
Topics: 1-Methyl-3-isobutylxanthine; Analysis of Variance; Bucladesine; Cell Adhesion; Cells, Cultured; Cyclic AMP; Deferoxamine; Endothelium, Vascular; Free Radical Scavengers; Glutathione; Humans; Hydrogen Peroxide; Hydroxyl Radical; Hypoxanthine; Isoproterenol; Neutrophils; Pentoxifylline; Tetradecanoylphorbol Acetate; Thrombin; Transferrin; Umbilical Veins; Xanthine Oxidase | 1996 |
Cardiopulmonary bypass alters vasomotor regulation of the skeletal muscle microcirculation.
Topics: Acetylcholine; Adenylyl Cyclases; Adrenergic beta-Agonists; Animals; Cardiopulmonary Bypass; Colforsin; Deferoxamine; Guanylate Cyclase; Hydroxyethyl Starch Derivatives; In Vitro Techniques; Isoproterenol; Isotonic Solutions; Microcirculation; Muscle, Skeletal; Nitroprusside; Ringer's Lactate; Sheep; Vasoconstriction; Vasodilation; Vasomotor System | 1997 |
Na+/H+ exchange in vascular smooth muscle cells is controlled by GTP-binding proteins.
Topics: Aluminum Chloride; Aluminum Compounds; Amiloride; Animals; Aorta; Biological Transport; Calcium; Cell Membrane Permeability; Cells, Cultured; Chlorides; Cyclic AMP; Deferoxamine; GTP-Binding Proteins; Guanosine 5'-O-(3-Thiotriphosphate); Guanosine Diphosphate; Hydrogen-Ion Concentration; Isoproterenol; Kinetics; Male; Muscle, Smooth, Vascular; Oligonucleotides, Antisense; Potassium; Rats; Rats, Inbred BN; Sodium; Sodium Fluoride; Thionucleotides | 1998 |
Deferoxamine blocks interactions of fluoride and carbachol in isolated mammalian cardiac preparations.
Topics: Adrenergic beta-Agonists; Animals; Carbachol; Deferoxamine; Fluorides; Guinea Pigs; Heart; In Vitro Techniques; Iron Chelating Agents; Isoproterenol; Muscarinic Agonists; Myocardial Contraction; Myocardium; Papillary Muscles; Phosphoprotein Phosphatases; Rats | 1998 |
Voltage-activated K+ channels and membrane depolarization regulate accumulation of the cyclin-dependent kinase inhibitors p27(Kip1) and p21(CIP1) in glial progenitor cells.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Animals; Cell Cycle Proteins; Cell Division; Cell Lineage; Cerebellum; Colforsin; Cyclin D; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Cyclins; Deferoxamine; Ion Channel Gating; Isoproterenol; Membrane Potentials; Mice; Microtubule-Associated Proteins; Oligodendroglia; Potassium; Potassium Channel Blockers; Potassium Channels; Rats; Rats, Sprague-Dawley; Sirolimus; Stem Cells; Tetraethylammonium; Tumor Suppressor Proteins; Veratridine | 1999 |
Oxidant-increased endothelial permeability: prevention with phosphodiesterase inhibition vs. cAMP production.
Topics: Adrenergic beta-Agonists; Animals; Capillary Permeability; Chelating Agents; Cyclic AMP; Deferoxamine; Endothelium, Vascular; Hydrogen Peroxide; In Vitro Techniques; Isoproterenol; Lung; Male; Organ Size; Perfusion; Phosphodiesterase Inhibitors; Pyrimidinones; Rats; Rats, Sprague-Dawley; Serum Albumin, Bovine | 2000 |
Leukocyte adhesion and microvessel permeability.
Topics: Adrenergic beta-Agonists; Animals; Blood Flow Velocity; Capillary Permeability; Cell Adhesion; Cell Count; Chelating Agents; Deferoxamine; Histamine H1 Antagonists; In Vitro Techniques; Isoproterenol; Ketotifen; Leukocytes; Male; Mast Cells; Mesentery; Microcirculation; Oxidative Stress; Perfusion; Rana pipiens; Venules | 2000 |
The novel iron chelator, 2-pyridylcarboxaldehyde 2-thiophenecarboxyl hydrazone, reduces catecholamine-mediated myocardial toxicity.
Topics: Animals; Catecholamines; Cell Line; Deferoxamine; Iron; Iron Chelating Agents; Isoproterenol; Male; Myocytes, Cardiac; Oxidation-Reduction; Rats; Rats, Wistar; Thiophenes | 2009 |
Iron deficiency attenuates catecholamine‑stimulated lipolysis via downregulation of lipolysis‑related proteins and glucose utilization in 3T3‑L1 adipocytes.
Topics: 3T3-L1 Cells; Adipocytes; Animals; Catecholamines; Deferoxamine; Down-Regulation; Glucose; Iron; Iron Deficiencies; Isoproterenol; Lipase; Lipid Metabolism; Lipolysis; Mice; Obesity; Perilipin-1; Siderophores; Sterol Esterase | 2020 |
Catalytic iron mediated renal stress responses during experimental cardiorenal syndrome 1 ("CRS-1").
Topics: Animals; Biomarkers; Cardio-Renal Syndrome; Cell Line; Deferoxamine; Gene Expression Regulation; Heart Failure; Heme Oxygenase-1; Humans; Interleukin-6; Iron; Isoproterenol; Kidney Diseases; Kidney Tubules, Proximal; Mice; Siderophores | 2021 |